STAR SPORTS MED1609.HKValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Deeply Undervalued” zone.
As of Oct 16, 2026, STAR SPORTS MED (1609.HK) trades at a P/E of 25.60x, P/B of 2.45x, P/S of 7.50x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 8th percentile over the trailing 10Y window (vs. 8th percentile over 3Y); P/B sits at the 8th percentile over the trailing 10Y window (vs. 8th percentile over 3Y); P/S sits at the 8th percentile over the trailing 10Y window (vs. 8th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 55th percentile within its industry and the 80th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.16%, ranking at the 100th percentile over the trailing 20Y window.
Cross-checking P/E against P/B, the two percentiles sit within 0.0 points of each other — a consistent signal from both angles. The P/E percentile sits lower within its industry than across the market as a whole — relatively cheaper next to direct peers. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. STAR SPORTS MED operates in the — sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: HKG: 1609 · SEHK: 1609 · 1609
Want the full picture on whether STAR SPORTS MED (1609.HK) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 25.60 | ||||||
| P/B (MRQ) | 2.45 | ||||||
| P/S (TTM) | 7.50 | ||||||
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 0.16% |